首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Oral paclitaxel with encequidar: The first orally administered paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: A phase III clinical study in metastatic breast cancer

【24h】

Oral paclitaxel with encequidar: The first orally administered paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: A phase III clinical study in metastatic breast cancer

机译：口腔紫杉醇具有脑探伤：第一个口服施用的紫杉醇显示出优于IV紫杉醇，在确认的反应和生存中具有较少的神经病理：癌症乳腺癌中的III期临床研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. Oral paclitaxel with encequidar: The first orally administered paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: A phase III clinical study in metastatic breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：口腔紫杉醇具有脑探伤：第一个口服施用的紫杉醇显示出优于IV紫杉醇，在确认的反应和生存中具有较少的神经病理：癌症乳腺癌中的III期临床研究
2. Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer [J] . Carol M. Moinpour, Gary W. Donaldson, Astra M. Liepa, Quality of Life Research . 2012,第5期

机译：在具有大量不可忽视的缺失数据和异质性反应的临床试验中评估与健康相关的生活质量治疗效果：吉西他滨联合紫杉醇与紫杉醇单药治疗转移性乳腺癌患者的III期随机试验结果
3. Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer. [J] . Carol M Moinpour, Gary W Donaldson, Astra M Liepa, Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation . 2012,第5期

机译：在具有大量不可忽视的缺失数据和异质性反应的临床试验中评估与健康相关的生活质量治疗效果：吉西他滨联合紫杉醇与紫杉醇单一疗法对转移性乳腺癌患者进行的III期随机试验的结果。
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Cost-Benefit Analysis of Nanoparticle Albumin-Bound Paclitaxel versus Solvent-Based Paclitaxel for the Treatment of Metastatic Breast Cancer in the United States [D] . Vichansavakul, Kittaya 2013

机译：纳米白蛋白结合紫杉醇与溶剂型紫杉醇在美国治疗转移性乳腺癌的成本效益分析
6. Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer [O] . H H Helgason, C M F Kruijtzer, A D R Huitema, 2006

机译：蒽环类药物治疗转移性乳腺癌患者口服紫杉醇（Paxoral）加环孢素的II期和药理研究
7. Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer [O] . Helgason, H H, Kruijtzer, C M F, Huitema, A D R, 2006

机译：蒽环类药物治疗转移性乳腺癌患者口服紫杉醇（Paxoral）加环孢素的II期和药理研究

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号